Decreasing Chronic Lung Disease Associated with Bubble CPAP Technology: Experience at Five Years

Area of Science:

• Neonatal Medicine
• Pediatric Respiratory Care
• Critical Care

Background:

• Bubble continuous positive airway pressure (bCPAP) is linked to reduced chronic lung disease (CLD) risk in preterm infants.
• This study investigates bCPAP's effectiveness in a community hospital NICU for respiratory complications and medication reduction.

Purpose of the Study:

• To evaluate the impact of implementing a bCPAP protocol in a NICU setting.
• To compare respiratory outcomes and medication usage between neonates receiving bCPAP and those on conventional ventilation.

Main Methods:

• Retrospective analysis comparing 45 neonates on bCPAP with 87 neonates on conventional ventilation.
• Data collection included medication usage and duration of oxygen and conventional ventilation support.

Main Results:

• The bCPAP group showed significantly decreased days on oxygen (median 33 vs 0) and conventional ventilation (median 18 vs 0).
• Chronic lung disease (CLD) incidence dropped from 30% to 4% post-bCPAP implementation (P = 0.002).
• Sedative medication use was significantly lower in the bCPAP group (mean 1.43 doses vs 5.20 doses; P < 0.001).

Conclusions:

• bCPAP implementation leads to substantial reductions in conventional ventilation requirements.
• The use of bCPAP significantly lowers the risk of chronic lung disease (CLD) in preterm neonates.
• bCPAP is associated with a decreased need for sedative medications in the NICU population.